# Haleon PLC 19.4% potential upside indicated by Berenberg Bank

- Link: https://www.directorstalkinterviews.com/haleon-plc-19-4-potential-upside-indicated-by-berenberg-bank/4121168268
- Published: 2024-08-13T12:35:18+01:00
- Author: Charlotte Edwards

**Haleon PLC** with ticker (LON:HLN) now has a potential upside of 19.4% according
to Berenberg Bank.
HLN.LBerenberg Bank set a target price of 447 GBX for the company,
which when compared to the Haleon PLC share price of 375 GBX at opening today (13/
08/2024) indicates a potential upside of 19.4%. Trading has ranged between 308 (
52 week low) and 378 (52 week high) with an average of 14,526,160 shares exchanging
hands daily. The market capitalisation at the time of writing is £34,053,421,124.
Haleon plc is a consumer healthcare company. The Company’s product portfolio includes
five categories, including oral health, vitamins, minerals, and supplements (VMS),
pain relief, respiratory health, digestive health and others. The Company’s geographical
segments include North America, Europe, Middle East, Africa, and Latin America (
EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product
solutions for a range of respiratory issues, including cold and flu, nasal congestion,
coughs, and allergies. The Company’s digestive health and other product offerings
also include skin health and smoker’s health. Its oral health brands include Sensodyne,
Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and
Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain
relief brands include Voltaren, Panadol, and Advil. Its digestive health brands 
include TUMS, ENO, and Fenistil.

Share on: